The landscape of dementia prognosis has advanced considerably with the arrival of complex biomarkers, which include amyloid PET scans, tau imaging, and blood-dependent exams that will detect Alzheimer's pathology many years before symptoms arise. Although these technological advancements depict exceptional progress in being familiar with neurodegenerative conditions, they've not dimin... https://chelwoodz098htg1.wikinewspaper.com/user